Korea’s Gene Analysis Technology Goes Global with Spearhead Macrogen

Established in 1997, Macrogen — which offers gene analysis services — is one of the nation’s leading companies bringing Korea’s world-class gene analysis technology to the global market.
更多

Macrogen Receives CAP Accreditation in Two Clinical Laboratories in Korea

Macrogen, Inc. (KOSDAQ: 038290), received the College of American Pathologists (CAP) accreditation. The CAP Laboratory Accreditation Program is internationally recognized and the largest of its kind, accrediting more than 8,000 laboratories.

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice or pathology and laboratory medicine worldwide.
更多

Macrogen Becomes the First Clinical Lab in Korea to Receive CLIA Accreditation

• NGS labs in Seoul headquarters and Bundang Precision Medicine Center become the first in Korea to receive CLIA accreditation

• Only company in Korea with both CLIA and CAP-accredited NGS clinical laboratory

• Accreditation gives Macrogen an advantage in building genome big data with medical institutions around the world